
VenoStent
VenoStent is a YC Summer 2020 (S20) company. Based in Houston, TX, USA. Team of 17.
About VenoStent
Summary
VenoStent builds a bioabsorbable vascular wrap, SelfWrap, placed around blood vessels during dialysis access surgery to prevent site failure. Dialysis access sites fail in 50-60% of cases within the first year, forcing repeat procedures and reducing quality of life for end-stage renal disease patients. SelfWrap replaces the current standard of care, which offers no mechanical support to the vessel after surgery.
Go-to-market
VenoStent targets vascular surgeons and dialysis care providers, with a clinical trial underway to build the evidence base needed for hospital and health system adoption.
From the Y Combinator listing
Absorbable wrap for blood vessels
There are 10 million dialysis and bypass surgeries per year, but half of them fail. VenoStent saves lives with a wrap that goes around blood vessels during surgery so they don't fail.
Facts
- Healthcare / Healthcare -> Medical Devices
- Houston, TX, USA
- 17
- Active
- Growth
Founders (2)
- Geoffrey Lucks
- Tim Boire
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works